Table 2: Survival for ovarian cancer, POG/CCG intergroup trial 1990-96.
|
Stage |
Treatment |
6-year free survival (%) |
6-year survival (%) |
|
I |
S + PEB |
95 |
95.1 |
|
II |
S + PEB |
87.5 |
93.8 |
|
III |
S + HDP/EB vs PEB |
96.6 |
97.3 |
|
IV |
S + HDP/EB vs PEB |
86.7 |
93.3 |
B: bleomycin; E: etoposide;
B: bleomycin; P: cisplatin; HDP: high-dose cisplatin; S: surgery